Shahid Y, Anis MA, Abid S. Foregut tuberculosis: Too close but miles apart. World J Clin Cases 2024; 12(32): 6517-6525 [PMID: PMC11438638 DOI: 10.12998/wjcc.v12.i32.6517]
Corresponding Author of This Article
Shahab Abid, FACG, FRCP (Hon), MBBS, PhD, Professor, Department of Medicine, Section of Gastroenterology, Aga Khan University Hospital, Stadium Road, P O Box 3500, Karachi 74800, Pakistan. shahab.abid@aku.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Author contributions: Shahid Y designed the manuscript, wrote the manuscript and analyzed the data; Anis MA searched the articles and contributed to writing and designing of the manuscript; Abid S reviewed the manuscript, contributed to design of the manuscript and made corrections to the successive versions; All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflicting interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shahab Abid, FACG, FRCP (Hon), MBBS, PhD, Professor, Department of Medicine, Section of Gastroenterology, Aga Khan University Hospital, Stadium Road, P O Box 3500, Karachi 74800, Pakistan. shahab.abid@aku.edu
Received: March 28, 2024 Revised: June 12, 2024 Accepted: July 31, 2024 Published online: November 16, 2024 Processing time: 179 Days and 10.4 Hours
Abstract
The worldwide burden of tuberculosis (TB) has increased and it can involve virtually any organ of the body. Intestinal TB accounts for about 2% of the cases of TB worldwide. The ileocecal region is the most commonly affected site, and the foregut is rarely involved. The reported incidence is approximately 0.5%. Esophageal TB presents with dysphagia, weight loss, and hematemesis in rare cases. Gastroduodenal TB usually manifests with symptoms such as nausea, vomiting, weight loss, and sometimes with gastric outlet obstruction. Gastroscopy may reveal shallow ulcers in stomach and duodenal deformity when underlying TB is suspected, therefore histopathology plays pivotal role. On computed tomography, duodenal TB typically manifests as duodenal strictures predominantly, accompanied by extrinsic compression, and occasionally as intraluminal mass. But their diagnosis can easily be missed if proper biopsies are not taken and samples are not sent for GeneXpert testing, TB polymerase chain reaction investigation and histopathological analysis. Despite being in close proximity to the lungs, the esophagus and stomach are rare sites of TB. The reasons could be low gastric pH and acidity which does not let mycobacterium grow. But there are various case reports of TB involving the foregut. We have summarized the rare cases of foregut TB in different sections and highlighted the importance of esophagogastroduodenoscopy, histopathology and advanced techniques like endoscopic ultrasound in establishing the diagnosis.
Core Tip: Gastroduodenal tuberculosis (TB) often mimics peptic ulcer disease and malignancies, presenting with symptoms such as gastric outlet obstruction and hematemesis, which necessitate urgent gastroscopic intervention. Differentiating TB from other conditions based solely on endoscopic examination is challenging. Therefore, histopathological analysis and molecular tests like GeneXpert are crucial for an accurate diagnosis. We aim to delve into the intricate details of these unexpected findings, highlighting the diagnostic challenges they present and their potential impact on patient outcomes.
Citation: Shahid Y, Anis MA, Abid S. Foregut tuberculosis: Too close but miles apart. World J Clin Cases 2024; 12(32): 6517-6525
Tuberculosis (TB) is a perilous malady capable of afflicting virtually any organ system. The worldwide burden of TB approaches nearly 12 million cases. The 2013 report of the World Health Organization estimated the global annual incidence of TB was at 8.6 million, with 1.3 million individuals succumbing to the disease in the year 2012[1]. TB can occur in any part of gastrointestinal (GI) tract. Intestinal TB (ITB) accounts for about 2% of the cases of TB worldwide[2]. TB can affect the abdomen via various mechanisms. Firstly, mycobacterium enters the intestine via ingestion of infected milk or sputum, infecting the mucosal layer of the GI tract and forming epithelioid granulomas in the lymphoid tissue of the submucosa. Within a few weeks, caseous necrosis of these tubercles causes ulceration of the overlying mucosa and spreads to deeper layers, adjacent lymph nodes, and the peritoneum. Bacilli can also enter the portal circulation, affecting solid organs such as the liver, pancreas, and spleen but this is very rare. Secondly, spread can also occur via the blood if a focus of infection elsewhere in the body reaches abdominal solid organs, kidneys, lymph nodes, or the peritoneum. Thirdly, direct spread to the peritoneum can occur from adjacent infected sites and through lymphatic channels from infected nodes[1]. The ileocecal region is the most commonly affected site, followed by the small bowel in cases of ITB. The predominant involvement of the ileocecal area is attributed to the abundance of lymphoid tissue, fecal stasis, increased absorption, and the easy access of mycobacterium to the mucosal lining[3]. Most common symptoms manifesting in ITB are abdominal pain, fever, weight loss, anorexia, nausea and vomiting, and diarrhea[4]. The foregut is rarely involved. According to an autopsy series, the reported incidence was approximately 0.5%. Most common symptoms of gastroduodenal TB are abdominal pain and vomiting. Patients usually present with gastric outlet obstruction or GI hemorrhage. Gastroscopy may reveal shallow ulcers in stomach and duodenal deformity when there is underlying suspected TB, therefore histopathology plays pivotal role[5]. On computed tomography, duodenal TB typically manifests as duodenal strictures predominantly accompanied by extrinsic compression, and occasionally as intraluminal mass[6]. Endoscopic biopsies seldom reveal granulomas, primarily owing to the submucosal localization of these lesions and the inadequacy of routine endoscopic procedures to encompass the submucosal layer[7]. Sharma et al[8] reported that endoscopic ultrasonography (EUS) was an exemplary modality for both characterizing the lesion and acquiring a sample for cytological confirmation of the diagnosis. Recent data support the use of newer modalities that help in the diagnosis of TB. Traditional investigations such as culture, acid-fast bacilli (commonly referred to as AFB) staining, and histopathology have low sensitivities, necessitating the use of other diagnostic methods. Modern tests based on molecular techniques include GeneXpert, polymerase chain reaction (PCR), interferon-gamma release assays (commonly referred to as IGRAs), multiplex-PCR and immunological markers. These are anticipated to aid in diagnosing ITB. CD73 is an important immunological marker that can help differentiate between Crohn’s granulomas and TB granulomas. CD73 is found more in TB granulomas[9]. This editorial comments on the article about gastroduodenal TB and highlights the diagnostic difficulties faced by clinicians[10].
ESOPHAGEAL TB
Even in countries with the highest burden of TB, the esophagus is a rare site to be affected by mycobacterium. The incidence of esophageal TB is around 0.2%-1% in the GI tract[1,11]. The esophagus has dynamic mechanisms to protect its mucosa, including constant peristaltic movement, mucus, saliva, enzymes, stratified squamous epithelium, and other mucosal factors that may contribute to the low incidence of TB. Hence, primary esophageal TB is extremely rare, and secondary esophageal TB is more common[12]. Multiple theories have been postulated to predict the mechanisms by which the esophagus may become involved. Savage et al[13] discussed some mechanisms of spread, first mentioned by Rubinstein in 1958, including direct contact with sputum, via the pharyngeal or laryngeal route or extension via lymph nodes.
The clinical presentation may vary amongst patients, but the most frequent symptom of esophageal TB is dysphagia in 90% of cases[14], which is possibly related to factors such as mass compression by enlarged lymph nodes, mediastinal fibrosis or stricture, esophageal ulcer, or decreased peristaltic activity[12]. Other common symptoms include hematemesis, retrosternal pain, and cough during swallowing[15]. Coughing during meals indicates the possibility of an esophageal-tracheal fistula, present in 13%-50% of cases, which can cause aspiration of gastric contents into airway[16]. The presence of hematemesis also raises suspicion of a fistula[17]. Clinicians may confuse esophageal TB with esophageal cancer or Crohn’s disease because they have similar disease presentations, but their treatment options are entirely different[18].
Esophagogastroduodenoscopy (EGD) is the cornerstone in managing dysphagia. Diagnosing esophageal TB typically involves histopathology and TB PCR, although detecting caseating granulomas in endoscopic samples has limited sensitivity (25.0%-60.8%)[19]. Owing to the submucosal location of caseating granulomas, it is recommended that multiple biopsies be taken from the ulcer margins during EGD[18]. EUS is another useful modality that can accurately determine the specific layer of esophageal wall from which the lesion arises. In cases of submucosal pathologies, EUS-guided fine needle aspiration (FNA) is preferred over regular endoscopic biopsy because of its higher sensitivity[19]. For esophageal TB, the mainstay of treatment is anti-TB therapy, including all complicated cases[20,21]. Esophageal TB is initially treated for 2 months with isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by 4 months of isoniazid, rifampicin, and ethambutol[22]. Table 1 summarizes case reports of esophageal TB[11-13,15,17,18,22-32].
6-week history of dysphagia and retrosternal chest pain unrelieved by antacids
Barium swallow showed a 10 cm plaque-like mid-esophageal lesion. Biopsies taken during esophagoscopy were inconclusive. Repeat biopsy 1 month later demonstrated caseating granulomata in the submucosa. Treated with ATT
6-week history of dysphagia for solids and retrosternal pain
Barium meal: Extrinsic compression in the mid-esophagus. Chest X ray: Sub carinal lymphadenopathy; Mantoux test: Strongly positive at 1:10000; Endoscopic biopsies were non-specific. A diagnosis of esophageal TB was made on radiological appearances and strongly positive Mantoux test. Treated with ATT
Esophageal biopsies showed numerous epithelioid caseating granulomas. The PPD skin test, T-SPOT. TB assay and polymerase chain reaction testing for MTB were positive. Treated with ATT
Massive hematemesis without any history of dysphagia, odynophagia, regurgitation
Endoscopy showed multiple ulcers in proximal esophagus, biopsy of which received granulomatous lesions. AFB stain for MTB was negative, but a positive PCR. Patient died next day because of massive hematemesis
Endoscopic biopsy of a hyperemic patch in esophagus revealed granulomatous changes. AFB stain and PCR for MTB was negative. Patient died 3 days after hospitalization due to aspiration pneumonia
Progressive dysphagia for 3 months, weight loss, loss of appetite, intermittent fever
EGD followed by histopathological examination revealed epithelioid cell granulomas without caseous necrosis. Sputum examination for acid-fast bacilli was positive. Treated with ATT
1 month of dysphagia and odynophagia associated with low-grade fevers, dry cough, night sweats, anorexia, sore throat, and pound weight loss
EGD followed with esophageal biopsies showed active ulcerative and granulomatous esophagitis with mycobacterial organisms. AFB culture grew MTB and MTB PCR was positive. Treated with ATT
GASTRIC TB
TB involvement of the stomach has been reported to occur in 0.5%-3% of all cases of GI TB[33,34]. The incidence of gastroduodenal TB is 0.5%[9], and isolated gastric TB is even rarer, comprising 0.1%-2% of all cases of TB. Gastric TB has been reported to be more common in men than in women, with a ratio of 2.8:1[7]. Gastric TB may occur as a primary or secondary infection, usually secondary to pulmonary infection or as a part of multifocal GI TB or miliary TB[35]. Primary or isolated gastric TB is a rare occurrence, and the main reason for it may be the consumption of unpasteurized milk infected with bovine TB or a severely immunocompromised condition[36,37]. The rarity of gastric TB can be attributed to several factors, the lack of lymphoid tissue in the gastric mucosa, the high acidity and bactericidal properties of gastric acid, the rapid transit time of the stomach because of its continuous motor activity, which swiftly moves organisms through the stomach, and the intact gastric mucosa that contributes to the local immunity of the gastric wall[34,38,39]. The symptoms of gastric TB differ depending on the site involved[40]. Patients may present with abdominal pain, vomiting, fever, weight loss, lethargy, upper GI bleed, and gastric outlet obstruction[1].
The diagnosis of gastric TB is challenging, and endoscopy often plays a vital role. Gastroscopy usually reveals submucosal pathology or ulceration in mucosa. Lesions found by EUS are described as hypoechoic lesions in the lamina propria, making it difficult to distinguish from gastric stromal tumors. Percutaneous ultrasound-guided FNA, Tru-Cut biopsy, and EUS-guided FNA can aid in the diagnosis of TB because the lesions are often located in the submucosa; however, the diagnostic accuracy of histopathology in diagnosing gastric TB is low[41]. PCR of gastric aspirates is also useful in the diagnosis of gastric TB, but the specificity is only approximately 85%[42]. Table 2 summarizes case reports of gastric TB[40,41,43,44-54].
Loss of appetite, post-prandial epigastric pain, weight loss
Post- operation (on prediagnosis of gastric cancer) biopsy of tissue showed caseating granulomatous inflammation. TB PCR was positive. Treated with ATT
Upper abdominal pain and fatigue for 3 months along with 4 kg weight loss
Biopsy post ESD (done with suspected diagnosis of interstitial tumor) showed caseous granuloma. PPD skin test was positive. Treated with ATT for 6 months
Epigastric discomfort for 1 month along with palpable abdominal mass
Endoscopic biopsy showed necrotic granuloma with an abscess. AFB stain and PCR were positive for MTB. Due to resistance kanamycin, moxifloxacin, prothionamide and cycloserin and pyrazinamide were given for 1 year
Endoscopic biopsy specimen revealed caseating granulomas with AFB. Positive cultures for MTB
DUODENAL TB
Duodenal TB comprises 2%-2.5% of cases of GI TB, which most commonly affects the third part of duodenum[1]. Gupta et al[55] described the characteristics of duodenal TB, which include inflammatory changes in duodenal mucosa, narrowing of duodenal lumen and granulomas seen on histopathology. Most of the published case reports describe duodenal TB as presenting with weight loss, persistent vomiting, and gastric outlet obstruction[56]. Gastric outlet obstruction can occur via two mechanisms, intrinsic (due to mucosal involvement), or extrinsic (due to external compression of enlarged lymph nodes)[57]. Duodenal TB frequently faces challenges in accurate diagnosis, often leading to its misidentification as Crohn's disease. The presence of granulomas in a duodenal stricture, particularly in the absence of caseating lesions and when accompanied by a sinus tract, complicates the differentiation between duodenal TB and Crohn's disease. This complexity may result in delays in administering appropriate anti-TB treatment and the unfortunate initiation of corticosteroid therapy. The key to a definitive diagnosis lies in identifying mycobacteria in gastroduodenal lavage material, biopsy specimens, or direct detection by acid-fast staining or culture. Therefore, a cautious approach to steroid administration is warranted when Crohn's disease is suspected. Comprehensive investigations should be conducted to exclude the possibility of ITB[58]. As per the guidelines, a conclusive diagnosis of GI TB is attainable when any of the following four criteria are met, detection of AFB, a positive result in TB PCR testing, the presence of caseating granulomas, or a positive TB culture obtained from a biopsy specimen. Nevertheless, establishing a diagnosis of duodenal TB using regular biopsy material is infrequent due to the predominant localization of TB granulomas in the submucosa[59]. Therefore deeper EUS-guided biopsies may have a higher diagnostic yield[60]. Duodenal TB case reports are summarized in Table 3[56-58,60,61-69].
EUS-FNA biopsy of duodenum showed caseating granulomas with multinucleated giant cells, and AFB were positive by Ziehl–Nielsen staining. Underwent laparoscopic gastrojejunostomy, and ATT after surgery
Recurrent vomiting, weight loss, thickened duodenum seen on CT scan and endoscopy
Histopathology revealed features of chronic inflammation, giant cells, and granulomas. Ziehl–Nielsen stain of tissue specimens was positive for AFB. Treated with ATT for 8 months
CONCLUSION
Despite being in close proximity to the lungs, the esophagus and stomach are rare sites of TB. The reasons could be low gastric pH and acidity which do not let mycobacterium grow. However, the case reports mentioned earlier are examples of uncommon instances where typical symptoms such as vomiting, weight loss, or abdominal pain occur. If these symptoms are overlooked or not thoroughly investigated, they can easily go unnoticed. Foregut TB frequently eludes a correct diagnosis by clinicians owing to superficial biopsies and the omission of tissue analysis for Mycobacterium tuberculosis PCR and GeneXpert testing. When TB is strongly suspected, conducting a thorough diagnostic examination is essential to minimize morbidity. TB is a manageable condition, hence swift diagnosis and appropriate treatment can help alleviate complications. EUS-FNA helps to obtain deeper core tissue samples, which have a positive yield in histopathology compared with superficial biopsies obtained with forceps. Therefore employing advanced endoscopic techniques such as EUS may prove advantageous with a higher diagnostic yield. Clinicians should always suspect ITB, especially in low middle income countries where prevalence of TB is higher. This editorial intends to inform about newer modalities to consider that enhance diagnostic accuracy and improve patient care. In situations where there is a high suspicion of TB indicated by a mass-forming lesion, irregular mucosa, weight loss, vomiting, and biopsies have are for malignancy, specimens should be tested using GeneXpert and TB culture. Molecular studies, such as IGRA, may also provide valuable diagnostic information.
Footnotes
Provenance and peer review: Invited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Medicine, research and experimental
Country of origin: Pakistan
Peer-review report’s classification
Scientific Quality: Grade C
Novelty: Grade B
Creativity or Innovation: Grade B
Scientific Significance: Grade B
P-Reviewer: Aseni P S-Editor: Qu XL L-Editor: Filipodia P-Editor: Wang WB
Miah AR, Sharma YR, Rahman MT, Raihan A, Roy PK, Hasan M. Clinicopathological profile of patients with abdominal tuberculosis.J Nepal Health Res Counc. 2011;9:169-175.
[PubMed] [DOI][Cited in This Article: ]
Rao YG, Pande GK, Sahni P, Chattopadhyay TK. Gastroduodenal tuberculosis management guidelines, based on a large experience and a review of the literature.Can J Surg. 2004;47:364-368.
[PubMed] [DOI][Cited in This Article: ]
Ali AM, Mohamed YG, Mohamud AA, Mohamed AN, Ahmed MR, Abdullahi IM, Saydam T. Primary gastroduodenal tuberculosis presenting as gastric outlet obstruction: A case report and review of literature.World J Clin Cases. 2024;12:1536-1543.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (3)]
Zahra T, Ravikumar Y, Voloshyna D, Shams Y, Shaik TA, Sandhu QI, Sahtiya S, Saleem F, Ghaffari MAZ. An Unusual Presentation of Esophageal Tuberculosis: A Case Report.Cureus. 2022;14:e29642.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Mahmoudi M, Bradai S, Khsiba A, Mohamed AB, Bradai J, Medhioub M, Hamzaoui L, Azouz MM. Esophageal tuberculosis as an unusual cause of dysphagia: a case report.Pan Afr Med J. 2022;41:225.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Salad NM, Ali IA, Mohamed YG. A case report of medically managed esophageal fistula due to complicated esophageal tuberculosis.Int J Surg Case Rep. 2022;93:106883.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Baleguli V, Rizvi S, Varghese M, Ilyas J. A Rare Cause of Esophageal Dysphagia - Secondary Esophageal Tuberculosis.Cureus. 2022;14:e21019.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Tromba JL, Inglese R, Rieders B, Todaro R. Primary gastric tuberculosis presenting as pyloric outlet obstruction.Am J Gastroenterol. 1991;86:1820-1822.
[PubMed] [DOI][Cited in This Article: ]
Yan F, Yu X, Lei H, Chen Y, Wang J, Li J. A rare case of gastric fundus tuberculosis with nonspecific abdominal pain.J Int Med Res. 2021;49:3000605211033189.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Zhang W, Song F, Zhang Z, Yang J, Zhao L. Asymptomatic gastric tuberculosis in the gastric body mimicking an isolated microscopic erosion: A rare case report.Medicine (Baltimore). 2022;101:e28888.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 1][Reference Citation Analysis (0)]
Naouri C, Menecier P, Naouri A, Levenq P. [Duodenal tuberculosis: a difficult diagnosis].Presse Med. 1997;26:805-806.
[PubMed] [DOI][Cited in This Article: ]
Sato N, Shiobara M, Wakatsuki K, Suda K, Miyazawa K, Aida T, Watanabe Y, Tawada K, Matsubara Y, Hosokawa Y, Yoshioka S. Duodenal tuberculosis with gastric outlet obstruction: a case report of successful diagnosis and treatment, with review of literature.Surg Case Rep. 2024;10:42.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Moirangthem GS, Singh NS, Bhattacharya KN, Chito TH, Singh LD. Gastric outlet obstruction due to duodenal tuberculosis: a case report.Int Surg. 2001;86:132-134.
[PubMed] [DOI][Cited in This Article: ]